VT News
Roland Sallai

Roland Sallai

Ask VT AI
View News Summary
  • Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
  • Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
  • US and China agree to a one-year trade truce, pausing tariff threats and easing export controls, but core disputes remain unresolved.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
  • Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
  • US and China agree to a one-year trade truce, pausing tariff threats and easing export controls, but core disputes remain unresolved.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Roland Sallai

Top Topics

Trending in U.S.

World

Sport